Psych News Alert | TMS

Reviewing Significant FDA Psychiatry Approvals in 2025

12/29/25 11:00 AM

January The FDA approves the esketamine nasal spray Spravato as a monotherapy for adults with treatm...

TMS May Enhance Language Therapy for Primary Progressive Aphasia

8/12/25 12:00 AM

TMS May Be More Effective With Symptom Provocation for OCD, Nicotine Dependence

6/5/25 12:30 PM

Individuals with obsessive-compulsive disorder (OCD) or nicotine dependence may have an improved res...

Condensed, High Intensity TMS Found Effective in Patients With Treatment-Resistant Depression

3/6/25 12:00 AM

TMS More Effective Than Next-Step Antidepressant Treatment, Study Shows

8/7/24 12:00 AM

FDA Clears Novel, Rapid-Acting TMS System for Treatment-Resistant Depression

6/24/24 11:16 AM

Low-Frequency TMS Improves Schizophrenia-Related Psychomotor Symptoms

3/4/24 12:00 AM

Study Supports Repetitive TMS for Patients With Treatment-Resistant Depression

1/30/23 12:00 AM

AJP Editors Identify Top Studies in 2022 That May Have Significant Impact in Psychiatry

1/3/23 12:00 AM